Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

PR Newswire

MORRISTOWN, N.J., June 19, 2025

MORRISTOWN, N.J. , June 19, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today that Dave Lennon , PhD, President and CEO, and David Dornan , PhD, Chief Scientific Officer, will participate in the virtual H.C. Wainwright "HCW@Home" series on Thursday, June 26, 2025, at 10 AM ET .

To register in advance, please use this link . A live webcast of the event can be accessed by visiting the "Investors & News" page on the Whitehawk Therapeutics website  and will be available for replay for approximately 30 days following the event.

About Whitehawk Therapeutics 

Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available at www.whitehawktx.com and connect with us on LinkedIn.

Contact
IR@whitehawktx.com

Whitehawk Therapeutics, Inc. logo (PRNewsfoto/Whitehawk Therapeutics, Inc.)

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-hc-wainwright-hcwhome-series-302485848.html

SOURCE Whitehawk Therapeutics, Inc.

Läs mer på PR Newswire

Marknadsöversikt

1 DAG %

Senast

1 mån
Senaste aktieanalyserna på Placera
Kollage Analys Ny
Privatekonomi med Placeras expert
Karolina Placera

Karolina Palutko Macéus skriver om allt som har med privatekonomi att göra och hur du kan få mer pengar i plånboken.

Affärsvärlden
AFV

Är du kund hos Avanza? Just nu kan du få en unik rabatt på Affärsvärlden. Afv har 28 år i rad utsetts till Sveriges bästa affärsmagasin i en undersökning med börs-VD:ar, finanschefer, IR-chefer och aktieproffs.

Annons
Introduce

för börsens små- och medelstora företag.

Annons
Investtech

Här hittar du våra artiklar om teknisk analys i samarbete med Investtech.